GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_18810/2025

Pfizer SAS, Pfizer AB, Pfizer Luxembourg S.a.r.l., Pfizer Aps, Pfizer Corporation Austria GmbH, Pfizer S.r.l., Laboratórios Pfizer, Lda., Pfizer Oy

Datum
2025-04-22
Kammer
Milan (IT) Central Division- Section
Verfahrensart
Application Rop 265
Sprache
EN

Metadaten

Fall-IDORD_18810-2025-a3408808c434
Aktenzeichen
RegisterzeichenORD_18810/2025
EntscheidungsreferenzORD_18810/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 Milan - Central Division - First Instance - central division UPC_CFI_687/2024 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 22/04/2025 Claimants Pfizer Inc. Pfizer Europe MA EEIG Pfizer B.V. Pfizer S.A. Pfizer Manufacturing Belgium S.A. Pfizer Service Company S.R.L. Pfizer Pharma GmbH Pfizer Limited Counterclaimants Pfizer Corporation Austria GmbH Pfizer Aps Pfizer Oy Pfizer SAS Pfizer S.R.L. Laboratórios Pfizer, Lda Pfizer AB Pfizer Luxembourg S.A.R.L. Represented by Gareth Williams Defendant GlaxoSmithKline Biologicals SA Represented by Oliver Jan Juengst and Dr. Daniela Kinkeldey PATENT AT ISSUE 2 Patent no. Proprietor/s EP4183412 GlaxoSmithKline Biologicals SA DECIDING JUDGE: Full panel COMPOSITION OF PANEL – FULL PANEL Presiding judge Andre ...